Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Mouse study provides preliminary indications of the antitumor efficacy of AR-209

March 18, 1999

Clinical trials of needle-free delivery of DNA vaccine begin

March 18, 1999

Second prostate cancer study initiated with Multikine

March 16, 1999

Genzyme Molecular Oncology initiates clinical trials of combined-antigen melanoma vaccine

March 10, 1999

Techniclone to present clinical data on newly designated orphan drug at ASCO

March 10, 1999

Betathine approved for accelerated phase I/II trials in Canada

March 2, 1999

ImmunoGen discusses progress of tumor-activated prodrugs

March 2, 1999

Medarex reacquires worldwide rights to MDX-210

March 1, 1999

Immunomedics' new immunotoxin against CEA is first in its class

March 1, 1999

Corixa is first to achieve clinical testing of a microsphere-encapsulated peptide cancer vaccine

Feb. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...